Mitochondrial Disorders Withdrawn Phase 2 Trials for OT-15 (DB17950)

Also known as: Mitochondrial Disorder / Mitochondrial Diseases / Mitochondrial Disease / Mitochondrial cytopathy (disorder) / Mitochondrial cytopathy

IndicationStatusPhase
DBCOND0047871 (Mitochondrial Disorders)Withdrawn2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT03866954Trial of Erythrocyte Encapsulated Thymidine Phosphorylase In Mitochondrial Neurogastrointestinal EncephalomyopathyTreatment